Voltammetric determination of rosiglitazone in pharmaceutical preparations and human plasma

Analytical Letters

Volumn 41, Issue 5, 2008, Pages 806-821

  El Sherbiny, Dina ^a   El Enany, Nahed ^a   Belal, Fathalla ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Dosage forms; Polarography; Rosiglitazone; Spiked human plasma

Indexed keywords

EID: 41849098068     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710801935046     Document Type: Article

References (27)

1. Balfour, J.A. and Plosker, G.L. 1999. Rosiglitazone. Drugs, 57: 921-30.
2. Chou, C.C., Lee, M.R., Cheng, F.C., and Yang, D.Y. 2005. Solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry for determination of trace rosiglitazone in urine. J. Chromatogr. A, 1097: 74-83.
3. GlaxoSmithKline, AV: L19, Prescribing Information. http://www.gsk-ecs.com/news/private/AvandiaV L19 P.I.pdf (accessed March, 2007).
4. Gomes, P., Sippel, J., Jablonski, A., and Steppe, M. 2004. Determination of rosiglitazone in coated tablets by MEKC and HPLC methods. J. Pharm. Biomed. Anal., 36: 909-13.
5. Gomes, P. and Steppe, M. 2006. First-derivative spectrophotometry in the analysis of rosiglitazone in coated tablets. J,. AOAC Int., 89: 1296-9.
6. Guidance for Industry; Q2B of Analytical Procedures. Methodology; International Conference on Hormonization (ICH), November 1996. http://www.fda.gov/eder/guidance/1320fnl.pdf (accessed September 1, 2004).
7. He, J., Hu, Y.F., Duan, L.F., Tan, Z.R., Wang, L.S., Wang, D., Zhang, W., Li, Z., Liu, J., Tu, J.H., Yao, Y.M., and Zhou, H.H. 2007. Sensitive and selective liquid chromatography-mass spectrometry method for the quantification of rosiglitazone in human plasma. J. Pharm. Biomed. Anal., 43: 580-585.
8. Heyrovsky, J. and Kuta, J. 1965. Principles of Polarography; Czechoslovak Academy of Science: Prague.
9. Heyrovsky, J. and Zuman, P. 1968. Practical Polarography; Academic Press: London.
10. Hruska, M.W. and Frye, R.F. 2004. Simplified method for determination of rosiglitazone in human plasma. J. Chromatogr. B, 803: 317-20.
11. Jamali, B., Theill, G.C., and Sørensen, L.L. 2004. Generic, highly selective, and robust capillary electrophoresis method for separation of a racemic mixture of glitazone compounds. J. Chromatogr. A., 1049: 183-7.
12. Kim, K.A. and Park, J.Y. 2004. Simple and extractionless high-performance liquid chromatographic determination of rosiglitazone in human plasma and application to pharmacokinetics in humans. Biomed. Chromatogr., 18: 613-15.
13. Kolte, B.L., Raut, B.B., Deo, A.A., Bagool, M.A., and Shinde, D.B. 2003. Liquid chromatographic method for the determination of rosiglitazone in human plasma. J. Chromatogr. B, 788: 37-44.
14. Kolte, B.L., Raut, B.B., Deo, A.A., Bagool, M.A., and Shinde, D.B. 2004. Simultaneous determination of metformin in combination with rosiglitazone by reversed-phase liquid chromatography. J. Chromatog. Sci., 42: 70-3.
15. Lin, Z.J., Desai-Krieger, D., and Shum, L. 2004. Simultaneous determination of glipizide and rosiglitazone unbound drug concentrations in plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry. J. Chromatogr. B, 801: 265-272.
16. Mamidi, R.N., Benjamin, B., Ramesh, M., and Srinivas, N.R. 2003. Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard. Biomed. Chromatogr., 17: 417-20.
17. Mamidi, R.N., Chaluvadi, M.R., Benjamin, B., Ramesh, M., Katneni, K., Babu, A.P., Bhanduri, J., Rao, N.M., and Rajagopalan, R. 2002. HPLC method for the determination of rosiglitazone in human plasma and its application in a clinical pharmacokinetic study. Arzneim. Forsch., 52: 560-4.
18. Meites, L. and Israel, Y. 1961. Calculation of electrochemical kinetic parameters from polarographic current-potential curves. J. Am. Chem. Soc., 83: 4903-6.
19. Miller, J.N. and Miller, J.C. 2005. Statistics and Chemometrics for Analytical Chemistry, 5th edn.; Prentice Hall: England.
20. Muxlow, A.M., Fowles, S., and Russell, P. 2001. Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasma. J. Chromatogr. B, 752: 77-84.
21. Oelschlaeger, H. and Knoth, H. 1998. Polarographic Analysis of Omeprazole Formulations. Pharmazie, 53: 242-4.
22. Proszt, J., Cieleszky, V., and Gyorbiro, K. 1967. Polarography; Akademiai Kiado: Budapest.
23. Radhakrishna, T., Satyanarayana, J., and Satyanarayana, A. 2002. LC determination of rosiglitazone in bulk and pharmaceutical formulation. J Pharm. Biomed. Anal., 29: 873-80.
24. Venkatesh, P., Harisudhan, T., Choudhury, H., Mullangi, R., and Srinivas, N.R. 2006. Simultaneous estimation of six antidiabetic drugs - glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide, and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay. Biomed. Chromatogr., 20: 1043-8.
25. Yardimci, C. and Özaltin, N. 2005. Method development and validation for the simultaneous determination of rosiglitazone and metformin in pharmaceutical preparations by capillary zone electrophoresis. Anal. Chim. Acta, 549: 88-95.
26. Yardimci, C., Özaltin, N., and Gürlek, A. 2007. Simultaneous determination of rosiglitazone and metformin in plasma by gradient liquid chromatography with UV detection. Talanta, 72: 1416-22.
27. Zhang, L., Tian, Y., Zhang, Z., and Chen, Y. 2007. Simultaneous determination of metformin and rosiglitazone in human plasma by liquid chromatography/tandem mass spectrometry with electrospray ionization: application to a pharmacokinetic study. J. Chromatogr. B, 854: 91-8.